Verastem, Inc. (VSTM)
NASDAQ · Manufacturing · Pharmaceutical preparations
$7.74−$0.0600 (−0.77%) on the dayAs of the close; data may be delayed.
VSTM price, last 12 months
Key stats
- Previous close
- $7.80
- Open
- $7.86
- Day range
- $7.67 – $7.89
- 52-week range
- $3.43 – $10.82
- Volume
- 891.8K
- Avg volume (20 days)
- 2.4M
- Market cap
- $701.0M
Performance
1W+4.0%
1M+4.7%
3M+104.8%
6M+46.3%
YTD+0.3%
1Y−10.1%
vs S&P 500, 1Y−26.9 pts
Technicals and fundamentals
About Verastem, Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $701.0M